Take Your Trading To The Next Level. Get Started Here!

Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival

April 9, 2024 Comments Off

J&J’s cell therapy is now approved for an earlier line of treatment than a competing drug from Bristol Myers. Meanwhile, a look at Mount Sinai’s approach to AI.